2018 Annual Meeting | E100 - How to Increase Investments in Neuroscience Research

Date Thursday 04/26/18

Time 12:00 PM - 12:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Policy, Practice, and Performance: Staying Ahead of Change)

Director(s) David Q. Beversdorf, MD, FAAN

Topic(s)

CME Available 0.00 credit

Program Tracks Business of Neurology

Event Timeline
03:30 PM - 04:00 PM	Speaker	How to Increase Investments in Neuroscience Research David Q. Beversdorf, MD, FAAN

Faculty Disclosures
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Human Biosciences. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Stalicla. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scioto. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from BionexusKC. The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $10,000-$49,999 for serving as a Case Consultant with Best Doctors.